CORBUS PHARMACEUTICALS HLD. - Daily - Technical analysis published on 06/15/2021 (GMT)
- 249
- 0
Oops, I was wrong about that analysis. My threshold for invalidation has been broken.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : INVALID
A split or consolidation has occurred on this instrument. There is no more graph available on this analysis.
Summary of the analysis
Trends
Short term:
Strongly bullish
Underlying:
Bullish
Technical indicators
61%
6%
33%
My opinion
Bullish above 2.01 USD
My targets
2.45 USD (+14.35%)
2.72 USD (+27.24%)
My analysis
In the short term, there could be an acceleration of the basic bullish trend on CORBUS PHARMACEUTICALS HLD.. This is a positive signal for buyers. As long as the price remains above 2.01 USD, a purchase could be considered. The first bullish objective is located at 2.45 USD. The bullish momentum would be boosted by a break in this resistance. Buyers would then use the next resistance located at 2.72 USD as an objective. Crossing it would then enable buyers to target 3.43 USD. In the event of a return below 2.01 USD, the price would probably only initiate a small short-term correction to improve the bullish trend. Trading this correction may be risky.
In the very short term, the general bullish sentiment is confirmed by technical indicators. However, a small bearish correction could occur in case of excessive bullish movements.
Force
0
10
6.4
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by DipFarda. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
The CORBUS PHARMACEUTICALS HLD. rating is 2.14 USD. The price registered a decrease of -1.84% on the session and was between 2.12 USD and 2.21 USD. This implies that the price is at +0.94% from its lowest and at -3.17% from its highest.2.12
2.21
2.14
A bearish opening was detected by the Central Gaps scanner. Sellers are trying to impose a bearish trend in the very short term.
Bearish opening
Type : Bearish
Timeframe : Openning
Here is a more detailed summary of the historical variations registered by CORBUS PHARMACEUTICALS HLD.:
Near a new HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Technical
Technical analysis of this Daily chart of CORBUS PHARMACEUTICALS HLD. indicates that the overall trend is bullish. 78.57% of the signals given by moving averages are bullish. This bullish trend is supported by the strong bullish signals given by short-term moving averages. An assessment of moving averages reveals a bullish signal that could impact this trend:
Moving Average bullish crossovers : AMA20 & AMA50
Type : Bullish
Timeframe : Daily
The technical indicators are bullish. There is still some doubt about the price increase.
But beware of excesses. The Central Indicators scanner currently detects this:
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : Daily
No signals are given by Central Patterns, a market scanner specialised in chart patterns, resistances and supports.
The Central Candlesticks scanner which studies Japanese candlesticks did not detect anything.
ProTrendLines
S2
S1
R1
R2
R3
Price
S2 | S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|---|
ProTrendLines | 0.94 | 1.91 | 2.14 | 3.43 | 4.64 | 7.77 |
Change (%) | -56.07% | -10.75% | - | +60.28% | +116.82% | +263.08% |
Change | -1.20 | -0.23 | - | +1.29 | +2.50 | +5.63 |
Level | Intermediate | Major | - | Intermediate | Minor | Minor |
Attention could also be paid to pivot points to set price objectives:
Daily
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 2.01 | 2.07 | 2.10 | 2.16 | 2.19 | 2.25 | 2.28 |
Camarilla | 2.12 | 2.12 | 2.13 | 2.14 | 2.15 | 2.16 | 2.17 |
Woodie | 2.01 | 2.06 | 2.10 | 2.15 | 2.19 | 2.24 | 2.28 |
Fibonacci | 2.07 | 2.10 | 2.12 | 2.16 | 2.19 | 2.21 | 2.25 |
Weekly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 2.01 | 2.07 | 2.10 | 2.16 | 2.19 | 2.25 | 2.28 |
Camarilla | 2.12 | 2.12 | 2.13 | 2.14 | 2.15 | 2.16 | 2.17 |
Woodie | 2.01 | 2.06 | 2.10 | 2.15 | 2.19 | 2.24 | 2.28 |
Fibonacci | 2.07 | 2.10 | 2.12 | 2.16 | 2.19 | 2.21 | 2.25 |
Monthly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 0.81 | 1.08 | 1.63 | 1.90 | 2.45 | 2.72 | 3.27 |
Camarilla | 1.95 | 2.02 | 2.10 | 2.17 | 2.25 | 2.32 | 2.40 |
Woodie | 0.94 | 1.15 | 1.76 | 1.97 | 2.58 | 2.79 | 3.40 |
Fibonacci | 1.08 | 1.40 | 1.59 | 1.90 | 2.22 | 2.41 | 2.72 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
Technical indicators
Moving averages
RSI (14): | 60.37 | |
MACD (12,26,9): | 0.1200 | |
Directional Movement: | 14.34 | |
AROON (14): | 28.57 | |
DEMA (21): | 2.12 | |
Parabolic SAR (0,02-0,02-0,2): | 2.08 | |
Elder Ray (13): | 0.11 | |
Super Trend (3,10): | 1.74 | |
Zig ZAG (10): | 2.14 | |
VORTEX (21): | 1.2200 | |
Stochastique (14,3,5): | 80.69 | |
TEMA (21): | 2.23 | |
Williams %R (14): | -23.02 | |
Chande Momentum Oscillator (20): | 0.28 | |
Repulse (5,40,3): | 0.2000 | |
ROCnROLL: | 1 | |
TRIX (15,9): | 0.7400 | |
Courbe Coppock: | 49.19 |
MA7: | 2.13 | |
MA20: | 1.94 | |
MA50: | 1.82 | |
MA100: | 2.08 | |
MAexp7: | 2.13 | |
MAexp20: | 1.99 | |
MAexp50: | 1.92 | |
MAexp100: | 2.02 | |
Price / MA7: | +0.47% | |
Price / MA20: | +10.31% | |
Price / MA50: | +17.58% | |
Price / MA100: | +2.88% | |
Price / MAexp7: | +0.47% | |
Price / MAexp20: | +7.54% | |
Price / MAexp50: | +11.46% | |
Price / MAexp100: | +5.94% |
Quotes :
-
15 min delayed data
-
NASDAQ Stocks
News
The latest news and videos published on CORBUS PHARMACEUTICALS HLD. at the time of the analysis were as follows:
- CORBUS INVESTOR ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc.; Investors with Over $100K in Losses are Encouraged to Contact the Firm - CRBP
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corbus Pharmaceuticals Holdings, Inc. - CRBP
- Corbus Pharmaceuticals Holdings, Inc. - CRBP Stock Chart Technical Analysis for 02-12-2019
- Corbus Pharmaceuticals Holdings, Inc. - CRBP Stock Chart Technical Analysis for 09-20-18
- Consolidated Research: 2018 Summary Expectations for CACI International, SELECT EGY SVCS, Internap, Sotheby's, Verint, and Corbus Pharmaceuticals — Fundamental Analysis, Key Performance Indications
This member declared not having a position on this financial instrument or a related financial instrument.
About author
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis CORBUS PHARMACEUTICALS HLD. - Daily